Reuters logo
BRIEF-Genticel completes milestone regarding use of GTL003 in vaccines
November 30, 2016 / 8:25 AM / 10 months ago

BRIEF-Genticel completes milestone regarding use of GTL003 in vaccines

Nov 30 (Reuters) - Genticel SA :

* Successfully completes determining milestone in partnership with Serum Institute regarding use of GTL003 in multivalent vaccines

* Company has also been granted us patent protecting Vaxiclase and GTL003 Source text for Eikon: [ID: nACT46545] Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below